Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 7, 1997

View Archived Issues

Tsumura describes agents for dermatitis

Chymase inhibitors from Green Cross

Peptide derivatives with antiinflammatory properties described by U.S. researchers

Rockefeller University discloses antibiotic peptides

Merck describes improved chemotherapeutic agents

Il Yang develops antitumor/immunostimulating proteoglycan

Antiallergic/antiinflammatory agents from Senju

Japanese researchers describe triazole antifungals

Nonantiresorptive substituted bisphosphonate disclosed by Gador

Legionella vaccine described by U.S. researchers

Promising new imaging agent for CNS disorders

Potential anticonvulsant described by CoCensys

Follow-up data reported for Amelorad

First launch for SCLC imaging agent

Promising data reported for fomivirsen

Isis updates activities related to ISIS-2302

Isis previews antisense anticancer program

Another Isis antisense compound to enter clinic

Progress in Bone Care's vitamin D pipeline

Zynaxis sells drug delivery technology

Alza signs licensing agreements for transdermal testesterone products

CEAPRO receives patent coverage for potential vaccine adjuvants

Cypress awarded grant for research related to its PROSORBA Column

Unigene Laboratories reveals bioequivalency results for osteoporosis drug

NIH funds development of antiplatelet agents from Cypress/PRP

RPR's docetaxel now approved in 49 countries

Pegasus completes acquisition

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...